|
||||
![]() Two independent entrepreneurs also committed to an investment of $1 million each. The remaining capital was raised through Agendia’s existing investor base. “The success of this financing round was aided by MammaPrint’s increasing U.S. demand, as well as growing reimbursement from private U.S. payors," says Dr. Bernhard Sixt, president and CEO of Agendia. "The proceeds will be used to accelerate the commercialization of MammaPrint in the U.S. market.” Dr. Sixt presented at the UBS Global Life Sciences Conference on Wednesday, September 23 at the Grand Hyatt hotel in New York. NEXT PAGE >> Related headlines West Coast University expands to North Hollywood Chapman report: Economic Forecast for the Legal Profession UC Irvine nets $320,000 to expand free online initiative Irvine’s Spectrum Pharmaceuticals raises $50 million Orange County loses more than 6,000 jobs over the month |
||||